Mahmoud Ismayl/X
Aug 9, 2025, 17:06
Mahmoud Ismayl: Meta-Analysis on Cerebral Embolic Protection in TAVR
Mahmoud Ismayl, Chief Cardiology Fellow and Assistant Professor at Mayo Clinic, shared an insightful post on X:
”Happy to share our updated meta-analysis of RCT’s on cerebral embolic protection (CEP) during TAVR following the BHF PROTECT-TAVI trial
CEP use was associated with:
- Stroke and disabling stroke
- All-cause mortality․”
Read the full article here.
Article: Routine Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials
Authors: Mahmoud Ismayl, Musa Mufarrih, Mackram F. Eleid, Charanjit S. Rihal, Mayra Guerrero
Read Hemostasis Today, stay updated on scientific advances in the field of hemostasis.
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis
-
Jul 8, 2026, 04:50Reza Bavarsad Shahripour: New AHA Guidance on Cryptogenic Stroke with Reduced Left Ventricular Function
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV
-
Jul 7, 2026, 22:52Harry Spoelstra: LongC0VID Still has Zero Proven Treatments
-
Jul 7, 2026, 22:39Satya K. Morar: Acute Portal Vein Thrombosis as an Exceptionally Rare Complication of Liver Biopsy in CVID
-
Jul 7, 2026, 22:23Aravind Palraj: Antiphospholipid Syndrome is not Just ‘Start Warfarin and Follow INR’